The growth in the historic period can be attributed to need for gastric protection of APIs, growth in oral solid dosage forms, early development of enteric coating polymers, rising chronic disease medication use, expansion of pharmaceutical manufacturing.
The growth in the forecast period can be attributed to increasing focus on patient friendly oral drugs, growth in modified release formulations, expansion of generic drug manufacturing, advancements in coating polymer technologies, rising demand for stability enhanced drug products. Major trends in the forecast period include growing demand for delayed release oral formulations, increased use of protective polymer coatings, expansion of targeted drug delivery systems, preference for moisture and acid resistant coatings, rising adoption in controlled release pharmaceuticals.
The increasing prevalence of bleeding disorders is expected to significantly drive the growth of the Koate-DVI market in the future. Bleeding disorders are conditions that impair the blood’s ability to clot properly, leading to excessive or prolonged bleeding. The rise in the prevalence of these disorders can be attributed to factors such as increased awareness and diagnosis, genetic factors, lifestyle changes, and improved screening methods. Koate-DVI plays a crucial role in managing bleeding disorders like hemophilia A by replacing the deficient factor VIII, enabling effective blood coagulation and reducing the risk of bleeding episodes. For instance, in May 2025, the World Federation of Hemophilia (WFH), a Canada-based international non-profit organization, reported that as of December 2024, the World Bleeding Disorders Registry included data from over 17,000 individuals across 124 hemophilia treatment centers in 47 countries, representing an 18.5% increase in registered individuals compared to 14,342 in 119 centers in 44 countries as of December 31, 2023. This rise in registered individuals highlights the increasing prevalence of bleeding disorders and, consequently, the growth of the Koate-DVI market.
The rise in healthcare expenditure is expected to significantly boost the Koate-DVI market in the future. Healthcare expenditure encompasses spending on medical services, infrastructure, pharmaceuticals, and other healthcare-related activities. This increase in expenditure is driven by factors such as rising operational costs, a higher prevalence of chronic and genetic disorders, advances in medical technology, and improved access to healthcare services. Koate-DVI plays a critical role in managing and preventing bleeding episodes in patients with hemophilia A, improving their quality of life and reducing the need for frequent hospital visits. For example, in May 2024, a report from the Office for National Statistics, a UK-based government agency, showed that total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the increase in healthcare expenditure is helping to drive the growth of the Koate-DVI market.
The growing aging population is also expected to propel the Koate-DVI market. Aging, the natural process of growing older, is characterized by a gradual decline in physiological functions and tissue integrity. The aging population is increasing due to factors such as longer life expectancy, declining birth rates, and advancements in healthcare that have improved longevity. Koate-DVI, a coagulation factor VIII therapy, is critical for managing bleeding episodes in elderly individuals with hemophilia A, helping to prevent complications and improve mobility and quality of life. For example, in January 2024, the Population Reference Bureau (PRB), a U.S.-based non-profit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), and their share of the overall population will grow from 17% to 23%. As a result, the rise in the aging population is further contributing to the expansion of the Koate-DVI market.
Major companies operating in the koate-dvi market are Grifols SA.
North America was the largest region in the koate-DVI market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the koate-dvi market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the koate-dvi market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs have impacted the koate-dvi market by increasing costs for specialty polymers, chemical intermediates, and pharmaceutical grade raw materials. These effects are most visible in oral solid dosage manufacturing facilities across import dependent regions such as asia pacific and europe. Higher tariffs can influence formulation costs and production scalability. However, tariffs are encouraging local sourcing of excipients and polymer manufacturing. This supports long term supply resilience for controlled release drug formulations.
The koate-dvi market research report is one of a series of new reports that provides koate-dvi market statistics, including koate-dvi industry global market size, regional shares, competitors with a koate-dvi market share, detailed koate-dvi market segments, market trends and opportunities, and any further data you may need to thrive in the koate-dvi industry. This koate-dvi market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Koate-DVI is a pharmaceutical coating polymer primarily used in delayed-release formulations. It is a divinyl adipate-based polymer designed to create a protective coating for oral tablets and capsules, ensuring controlled or delayed drug release in the digestive system. These polymers help protect active pharmaceutical ingredients (APIs) from the acidic environment of the stomach, enabling the drug to be released in the intestine or at a later time for more targeted and effective delivery. Koate is typically made from methacrylic acid derivatives or similar copolymers, forming a stable, uniform film around the drug to protect it from moisture, light, and heat.
The main indications for Koate-DVI include the treatment and prophylaxis of hemophilia A, as well as the management of bleeding episodes. Hemophilia A is a genetic bleeding disorder caused by a deficiency in factor VIII. Koate-DVI is available in injectable formulations, such as lyophilized powder and ready-to-use solutions, and is used by pediatric, adult, and geriatric patients. Distribution channels for Koate-DVI include direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies. It is administered by various healthcare providers, including hospitals, hemophilia treatment centers, specialty clinics, and home healthcare providers.
The koate-DVI market consists of sales of gastrointestinal (GI) drug delivery systems, delayed-release formulations, and pharmaceutical coatings. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The growth in the forecast period can be attributed to increasing focus on patient friendly oral drugs, growth in modified release formulations, expansion of generic drug manufacturing, advancements in coating polymer technologies, rising demand for stability enhanced drug products. Major trends in the forecast period include growing demand for delayed release oral formulations, increased use of protective polymer coatings, expansion of targeted drug delivery systems, preference for moisture and acid resistant coatings, rising adoption in controlled release pharmaceuticals.
The increasing prevalence of bleeding disorders is expected to significantly drive the growth of the Koate-DVI market in the future. Bleeding disorders are conditions that impair the blood’s ability to clot properly, leading to excessive or prolonged bleeding. The rise in the prevalence of these disorders can be attributed to factors such as increased awareness and diagnosis, genetic factors, lifestyle changes, and improved screening methods. Koate-DVI plays a crucial role in managing bleeding disorders like hemophilia A by replacing the deficient factor VIII, enabling effective blood coagulation and reducing the risk of bleeding episodes. For instance, in May 2025, the World Federation of Hemophilia (WFH), a Canada-based international non-profit organization, reported that as of December 2024, the World Bleeding Disorders Registry included data from over 17,000 individuals across 124 hemophilia treatment centers in 47 countries, representing an 18.5% increase in registered individuals compared to 14,342 in 119 centers in 44 countries as of December 31, 2023. This rise in registered individuals highlights the increasing prevalence of bleeding disorders and, consequently, the growth of the Koate-DVI market.
The rise in healthcare expenditure is expected to significantly boost the Koate-DVI market in the future. Healthcare expenditure encompasses spending on medical services, infrastructure, pharmaceuticals, and other healthcare-related activities. This increase in expenditure is driven by factors such as rising operational costs, a higher prevalence of chronic and genetic disorders, advances in medical technology, and improved access to healthcare services. Koate-DVI plays a critical role in managing and preventing bleeding episodes in patients with hemophilia A, improving their quality of life and reducing the need for frequent hospital visits. For example, in May 2024, a report from the Office for National Statistics, a UK-based government agency, showed that total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the increase in healthcare expenditure is helping to drive the growth of the Koate-DVI market.
The growing aging population is also expected to propel the Koate-DVI market. Aging, the natural process of growing older, is characterized by a gradual decline in physiological functions and tissue integrity. The aging population is increasing due to factors such as longer life expectancy, declining birth rates, and advancements in healthcare that have improved longevity. Koate-DVI, a coagulation factor VIII therapy, is critical for managing bleeding episodes in elderly individuals with hemophilia A, helping to prevent complications and improve mobility and quality of life. For example, in January 2024, the Population Reference Bureau (PRB), a U.S.-based non-profit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), and their share of the overall population will grow from 17% to 23%. As a result, the rise in the aging population is further contributing to the expansion of the Koate-DVI market.
Major companies operating in the koate-dvi market are Grifols SA.
North America was the largest region in the koate-DVI market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the koate-dvi market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the koate-dvi market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs have impacted the koate-dvi market by increasing costs for specialty polymers, chemical intermediates, and pharmaceutical grade raw materials. These effects are most visible in oral solid dosage manufacturing facilities across import dependent regions such as asia pacific and europe. Higher tariffs can influence formulation costs and production scalability. However, tariffs are encouraging local sourcing of excipients and polymer manufacturing. This supports long term supply resilience for controlled release drug formulations.
The koate-dvi market research report is one of a series of new reports that provides koate-dvi market statistics, including koate-dvi industry global market size, regional shares, competitors with a koate-dvi market share, detailed koate-dvi market segments, market trends and opportunities, and any further data you may need to thrive in the koate-dvi industry. This koate-dvi market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Koate-DVI is a pharmaceutical coating polymer primarily used in delayed-release formulations. It is a divinyl adipate-based polymer designed to create a protective coating for oral tablets and capsules, ensuring controlled or delayed drug release in the digestive system. These polymers help protect active pharmaceutical ingredients (APIs) from the acidic environment of the stomach, enabling the drug to be released in the intestine or at a later time for more targeted and effective delivery. Koate is typically made from methacrylic acid derivatives or similar copolymers, forming a stable, uniform film around the drug to protect it from moisture, light, and heat.
The main indications for Koate-DVI include the treatment and prophylaxis of hemophilia A, as well as the management of bleeding episodes. Hemophilia A is a genetic bleeding disorder caused by a deficiency in factor VIII. Koate-DVI is available in injectable formulations, such as lyophilized powder and ready-to-use solutions, and is used by pediatric, adult, and geriatric patients. Distribution channels for Koate-DVI include direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies. It is administered by various healthcare providers, including hospitals, hemophilia treatment centers, specialty clinics, and home healthcare providers.
The koate-DVI market consists of sales of gastrointestinal (GI) drug delivery systems, delayed-release formulations, and pharmaceutical coatings. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Koate-DVI Market Characteristics
3. Koate-DVI Market Supply Chain Analysis
4. Global Koate-DVI Market Trends and Strategies
5. Koate-DVI Market Analysis of End Use Industries
7. Global Koate-DVI Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Koate-DVI Total Addressable Market (TAM) Analysis for the Market
9. Koate-DVI Market Segmentation
10. Koate-DVI Market Regional and Country Analysis
11. Asia-Pacific Koate-DVI Market
12. China Koate-DVI Market
13. India Koate-DVI Market
14. Japan Koate-DVI Market
15. Australia Koate-DVI Market
16. South Korea Koate-DVI Market
17. Western Europe Koate-DVI Market
18. UK Koate-DVI Market
19. Germany Koate-DVI Market
20. France Koate-DVI Market
21. Eastern Europe Koate-DVI Market
22. North America Koate-DVI Market
23. USA Koate-DVI Market
24. Canada Koate-DVI Market
25. South America Koate-DVI Market
26. Middle East Koate-DVI Market
27. Africa Koate-DVI Market
29. Koate-DVI Market Competitive Landscape and Company Profiles
32. Koate-DVI Market High Potential Countries, Segments and Strategies
33. Appendix
Executive Summary
Koate-DVI Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses koate-dvi market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for koate-dvi? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The koate-dvi market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Indications: Treatment Of Hemophilia A; Prophylaxis For Hemophilia A; Management Of Bleeding Episodes2) By Formulations: Injectable Formulation (Lyophilized Powder); Ready-to-use Solutions
3) By Patient Demographics: Pediatric Patients; Adult Patients; Geriatric Patients
4) By Distribution Channel: Direct Sales; Wholesalers And Distributors; Retail Pharmacies; Online Pharmacies
5) By End Users: Hospitals; Hemophilia Treatment Centers; Specialty Clinics; Home Healthcare Providers
Companies Mentioned: Grifols SA
Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Koate-DVI market report include:- Grifols SA
